ONKO-INNATE
LIVE

Serial Number

79292390

Owner

oNKo-innate Pty Ltd

Attorney

Andrew S. Ehard

Filing Date

Jul 23, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ONKO-INNATE Trademark

Serial Number: 79292390 • Registration: 6617149

ONKO-INNATE is a trademark filed by oNKo-innate Pty Ltd on July 23, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

oNKo-innate Pty Ltd (4 trademarks)

27 Norwood Crescent

Entity Type: 99

Trademark Details

Filing Date

July 23, 2020

Registration Date

January 18, 2022

Published for Opposition

August 3, 2021

Goods & Services

Pharmaceutical drugs for the treatment of cancer and immune cell related disorders; pharmaceutical preparations for the treatment of cancer and immune cell related disorders; stem cells for medical purposes; living cells for medical use; pharmaceutical and biological preparations for the treatment of cancer; biological preparations for medical use for the treatment of cancer and immune cell related disorders; chemicals for pharmaceutical use for the treatment of cancer and immune cell related disorders

Scientific research; pharmaceutical research, development and testing services; scientific research, namely, preparation of scientific reports; advisory services relating to immunological product development and testing; scientific research, design, analysis and testing of pharmaceutical products; conducting scientific and medical research and clinical trials; scientific research in the field of immunology and cancer treatment; scientific research and testing in the field of natural killer cells; provision of scientific information in the field of immunology, cancer treatment and the treatment of immune cell related disorders; scientific and technical analysis, namely, scientific research, analysis and testing in the field of immunology, cancer treatment and the treatment of immune cell related disorders; scientific research consultancy in the field of immunology, cancer treatment and the treatment of immune cell related disorders; scientific research in the field of pharmacy; medical research; research and development of products; research relating to pharmaceuticals

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 18, 2022 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Aug 14, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 18, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 28, 2022 FICS
FINAL DISPOSITION PROCESSED
Jun 27, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 18, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 18, 2022 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Dec 12, 2021 ETOP
ASSIGNED TO EXAMINER
Nov 3, 2021 DOCK
EXTENSION OF TIME TO OPPOSE RECEIVED
Sep 1, 2021 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 3, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 3, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Aug 1, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 14, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 14, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 14, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 28, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 20, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 20, 2021 TROA
ATTORNEY REVIEW COMPLETED
Apr 6, 2021 ATRV
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Mar 24, 2021 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Feb 13, 2021 LIMG
REFUSAL PROCESSED BY IB
Dec 20, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 1, 2020 RFCS
REFUSAL PROCESSED BY MPU
Dec 1, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 14, 2020 RFCR
NON-FINAL ACTION WRITTEN
Nov 13, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 9, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 1, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 28, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 27, 2020 REPR